- Min.Order :1 Gram
- Purity: 2mg/vial,10vials/box
- Payment Terms : L/C,D/A,D/P,T/T,,MoneyGram,Other
Keywords
Cjc 1295 with dac cjc 1295 cjc
Quick Details
- Appearance:Lyophilized powder
- Application:body building, health supplement 863288-34-0
- PackAge:10vials/kit, box
- ProductionCapacity:1000|Metric Ton|Day
- Storage:Far from fire and heat, keep in cool place
- Transportation:by express, dhl,tnt,ems
Superiority:
1.Free sample and the price is reasonable.
2.low freight with the fast delivery.
3.payment assurance, 24 hours service,the goods is high purity,
4.It have good effect,good feedback, lead time:1-3 days,
5.payment terms: TT, alibaba, ,
6.factory supplier, recruit overseas agents, welcome inquiry.
CJC-1295 is a long-acting growth hormone releasing hormone that releases more growth hormone from the anterior pituitary. GHRH is released in the form of pulses in vivo, alternating with the corresponding pulses of somatostatin (growth hormone inhibitory hormone). Clinical studies were first conducted in the mid-2000s for CJC-1295. The purpose of this peptide is to treat visceral fat deposition in obese AIDS patients, as an increase in exogenous hgH levels is thought to increase lipolysis (fat reduction). Clinical studies have finally been successfully applied to most subjects.
Details:
| Name |
cjc 1295 |
|
| Molecular Formula | C152H252N44O42 | |
| Molecular Weight | 3367.897 | |
| CAS Registry Number | 863288-34-0 | |
| density | 1.4±0.1 g/cm3 | |
| Appearance | Freeze-dried powder | |
| Specification | 2mg/vial | |
| Category | API |
CJC-1295 is a long-acting GHRH analogue that stimulates the secretion of GH and IGF-1. It will maintain a steady increase in HGH and IGF-1 without an increase in prolactin. [1] CJC-1295 represents a very exciting new compound with the potential to increase the secretion and action of growth hormone and IGF-I, with built-in protective measures (feedback of IGF-I) that can limit GH Excessive elevation and IGF-1 levels. Strong fat loss. Increase protein synthesis and increase muscle growth. GHRHKO animals receiving a daily dose of CJC-1295 exhibited normal body weight and length.
Function of cjc 1295
CJC-1295 is a long-acting growth hormone releasing hormone that releases more growth hormone from the anterior pituitary. GHRH is released in the form of pulses in vivo, alternating with the corresponding pulses of somatostatin (growth hormone inhibitory hormone). Clinical studies were first conducted in the mid-2000s for CJC-1295. The purpose of this peptide is to treat visceral fat deposition in obese AIDS patients, as an increase in exogenous hgH levels is thought to increase lipolysis (fat reduction). Clinical studies have finally been successfully applied to most subjects.
COA of cjc 1295
You Might Also Like
-
Powder Azvudine 99% CAS 1011529-10-4
CAS NO:1011529-10-4
-
Factory Supply Scopolamine 99% CAS 51-34-3
CAS NO:51-34-3
-
Factory Supply Gibberellic acid 99% gibberellin CAS 77-06-5
CAS NO:77-06-5
-
Factory Supply 5-Fluorouracil 99% CAS 51-21-8
CAS NO:51-21-8
-
Factory supply Acarbose 99% CAS 56180-94-0
CAS NO:56180-94-0
-
Factory supply cobamamide 99% CAS 13870-90-1
CAS NO:13870-90-1
Related Searches
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View